Athlone, Ireland

Niall M M Fanning

This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: Elan Corporation, Plc. Active years: 2001-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Niall M M Fanning. Retrieved from https://idiyas.com/inventor/niall-m-m-fanning

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.2

ph-index = 4

Forward Citations = 907(Granted Patents)


Company Filing History:


Years Active: 2001-2005

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Journey of Niall M M Fanning

Introduction

Niall M M Fanning, an accomplished inventor based in Athlone, Ireland, has made significant contributions to the field of pharmacology through his innovative thinking and dedication. With a total of four patents to his name, Fanning's work primarily focuses on developing advanced drug delivery systems that enhance patient compliance and treatment efficacy.

Latest Patents

One of Fanning's notable inventions is the multiparticulate modified release composition. This invention delivers an active ingredient in a pulsed or bimodal manner, which is vital for optimizing therapeutic outcomes. The composition consists of an immediate release component and a modified release component. The immediate release component features a first population of active ingredient-containing particles, while the modified release component includes a second population of particles coated with a controlled release coating. This combination allows for precise delivery of the active ingredient in a unique way, improving the plasma profile and ultimately enhancing patient compliance by reducing the frequency of dosage.

Career Highlights

Fanning is currently associated with Elan Corporation, plc, a company known for its focus on biotechnology and pharmaceuticals. Throughout his career, Fanning has focused on innovations that aim to solve complex problems in medication delivery systems, pushing the boundaries of current pharmaceutical technology.

Collaborations

In the pursuit of his inventions, Fanning has collaborated with noteworthy colleagues, including John G Devane and Paul Stark. Their collective expertise has contributed to the refinements and successful implementations of Fanning's distinctive drug delivery systems.

Conclusion

Niall M M Fanning continues to make advancements in the pharmaceutical field, demonstrating a robust commitment to improving patient care through innovative drug delivery solutions. His inventive spirit and collaborative efforts underscore the importance of teamwork in the realm of scientific discovery and patentable innovations. As he progresses in his career, Fanning's contributions remain relevant in shaping the future of healthcare technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…